Sanofi

French pharmaceutical company

SAN Euronext Paris · home listing SNY NYSE ISIN FR0000120578 SEC CIK 1121404 LEI 549300E9PC51EN656011
Follow Sanofi Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 EUR · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
€0€20B€40B€60BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25€43.6B€7.8B
FY24€41.1B€5.6B
FY23€43.1B€5.4B
FY22€43B€8.4B
FY21€37.8B€6.2B
FY20€36B€12.3B
FY19€36.1B€2.8B
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2577.2%14.5%17.9%
FY2475.7%17.7%13.5%
FY2374.8%18.3%12.5%
FY2273.7%24.8%19.5%
FY2171.3%21.5%16.5%
FY2070%39.2%34.2%
FY1971%8.7%7.8%
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
€0€2.5B€5B€7.5B€10BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividendsBuybacks
FY25€4.8B€5B
FY24€4.7B€302M
FY23€4.5B€593M
FY22€4.2B€497M
FY21€4B€382M
FY20€3.9B€822M
FY19€3.8B€9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Sanofi
  • Healthcare median
−100%−50%0%50%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearSanofiHealthcare median
FY2517.9%−30.6%
FY2413.5%−47%
FY2312.5%−58%
FY2219.5%−80.4%
FY2116.5%−71.9%
FY2034.2%−62.2%
FY197.8%−46.3%